Bio

I make data accessible, actionable, and beautiful. I have over 10 years of experience curating datasets, analyzing data, and designing actionable data visualizations at the intersection of healthcare, public policy, and technology. My work has advanced research on rare diseases, informed global HIV-related policies, and helped launch new medical devices recognized as breakthroughs by the U.S. FDA.

My analyses inform practical, real-world decisions. I’ve designed dashboards that drove strategic decision-making by the U.S. CDC during natural disasters, and helped White House-level groups envision possible scenarios as they modeled decision-making during hypothetical future outbreaks. I helped to design and evaluate a digital therapeutic product for postpartum depression, and conducted analyses that inform how the U.S. FDA uses social media data to reduce medication errors. I’ve worked with ALS patients to improve the next-generation of power wheelchairs, and alongside UNAIDS to design data systems that characterize the impact of HIV-related laws and policies. My work has been published in peer-reviewed journals including JAMA and BMJ Global Health, used by the U.S. government to help measure and define “trustworthy” AI systems, and discussed at high-level United Nations and G20 meetings to create policy and economic guidelines for responding to infectious diseases. 

I love to ask questions. I’m a generalist and am often the “methods person” in a room full of experts, ranging from healthcare providers to diplomats, from legal experts to AI researchers. As I collaborate with them to make sense of their data and structure our findings, I have the privilege of learning from and with them. In doing so, sometimes I accidentally pick up some niche expertise of my own. For example, I may be the world’s leading expert in estimating the implementation costs of the International Health Regulations (2005), a legal framework that defines how countries have agreed to respond to public health events with the potential to cross borders. It’s a very specific skill set, but it’s come in handy a few times. I also love teaching, and I have taught data science courses at Carnegie Mellon, Georgetown University, and UC Berkeley.

I’m a gardener, a home cook, and a mom. I currently live in Berkeley, California, but have previously spent time in Los Angeles, Washington DC, Pittsburgh, NYC, and Boston. Outside of work, I find joy in running, growing obscure citrus trees, cooking big pots of beans, and chasing my very busy toddler around the park.

Education

UCSF & UC Berkeley

Health Innovation Fellow

Carnegie Mellon University

Masters degree in Statistical Practice

UCLA

Bachelors degree in Biochemistry

  • I have a masters degree in statistical practice from Carnegie Mellon University, and over ten years of experience working as an applied data scientist. I particularly love exploratory analysis, data visualization, and working with teams to refine the questions we're trying to answer. I've worked professionally with datasets ranging from clinical trial data for regulatory submission, to weblog data from the New York Times.

  • Most often, I write code in SQL, R, and Python. I also know a bit of SAS, Stata, and SPSS. I teach a graduate-level course on statistical programming at Georgetown University.

  • I've worked at digital health startups including PatientsLikeMe and Woebot, written peer-reviewed publications on the use of AI/ML in hospital settings, and designed online decision-support platforms used by organizations including the US CDC, World Bank, UNAIDS, and the Global Fund. My digital health research has been published in JAMA and BMJ Global Health.

  • I've collaborated with diplomats, health systems researchers, and legal scholars for nearly ten years, using data to inform critical policy decisions in global public health. My work has been featured in national and international venues including the US Department of Health and Human Services "Trustworthy AI Playbook", the UN Biological Weapons Convention Meeting of Experts, and by the High Level Independent Panel of the G20.

Technical expertise

Peer reviewed publications

Weets, C. M., Eaneff, S., & Katz, R. (2024). An incomplete picture: data limitations in costed National Action Plans for Health Security (NAPHS). BMJ Global Health, 9(2).

Eaneff S, Boyce MR, Graeden E, Lowrance D, Moore M, Katz R. Financing global health security: estimating the costs of pandemic preparedness in Global Fund eligible countries. BMJ Global Health. 2023 Jan 1;8(1).

Eaneff S, Graeden E, McClelland A, Katz R. Investing in global health security: estimating cost requirements for country-level capacity building. PLOS global public health. 2022 Dec 5;2(12).

Oskotsky T, Bajaj R, Burchard J, Cavazos T, Chen I, Connell WT, Eaneff S, Grant T, Kanungo I, Lindquist K, Myers-Turnbull D. Nurturing diversity and inclusion in AI in Biomedicine through a virtual summer program for high school students. PLoS computational biology. 2022 Jan 31;18(1).

Eaneff S, Obermeyer Z, Butte AJ. The case for algorithmic stewardship for artificial intelligence and machine learning technologies. Jama. 2020 Oct 13;324(14):1397-8.

Kavanagh MM, Graeden E, Pillinger M, Singh R, Eaneff S, Bendaud V, Gustav R, Erkkola T. Understanding and comparing HIV-related law and policy environments: cross-national data and accountability for the global AIDS response. BMJ global health. 2020 Sep 1;5(9):e003695.

Lee CT, Katz R, Eaneff S, Mahar M, Ojo O. Action-based costing for national action plans for health security: accelerating progress toward the International Health Regulations (2005). Health security. 2020 Jan 1;18(S1):S-53.

Katz R, Graeden E, Kerr J, Eaneff S. Tracking the flow of funds in global health security. Ecohealth. 2019 Jun 15;16(2):298-305.

Katz R, Graeden E, Abe K, Attal-Juncqua A, Boyce MR, Eaneff S. Mapping stakeholders and policies in response to deliberate biological events. Heliyon. 2018 Dec 1;4(12).

Katz R, Graeden E, Eaneff S, Kerr J. Strengthening health security: an intuitive and user-friendly tool to estimate country-level costs. BMJ Global Health. 2018 Aug 1;3(4):e000864.

Blaser DA, Eaneff S, Loudon-Griffiths J, Roberts S, Phan P, Wicks P, Weatherall J. Comparison of rates of nausea side effects for prescription medications from an online patient community versus medication labels: an exploratory analysis. AAPS Open. 2017 Dec;3(1):1-0.

Eaneff S, Wang V, Hanger M, Levy M, Mealy MA, Brandt AU, Eek D, Ratchford JN, Nyberg F, Goodall J, Wicks P. Patient perspectives on neuromyelitis optica spectrum disorders: data from the PatientsLikeMe online community. Multiple sclerosis and related disorders. 2017 Oct 1;17:116-22.